Vanda Pharmaceuticals Inc.·4

Dec 16, 4:38 PM ET

Williams Timothy 4

4 · Vanda Pharmaceuticals Inc. · Filed Dec 16, 2022

Insider Transaction Report

Form 4
Period: 2022-12-15
Williams Timothy
SVP & General Counsel
Transactions
  • Sale

    Common Stock

    2022-12-15$7.01/sh8,000$56,07087,551 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.946 to $7.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION